Research Topics
| Susan RehmSummaryAffiliation: Cleveland Clinic Foundation Country: USA Publications
| Collaborators
|
Detail Information
Publications
Identifying barriers to adult pneumococcal vaccination: an NFID task force meetingSusan J Rehm
Department of Infectious Diseases, Cleveland Clinic, Cleveland, OH 44195, USA
Postgrad Med 124:71-9. 2012..All health care providers need to accept responsibility for vaccination so that this preventive measure becomes a high priority in the care of patients at risk for serious pneumococcal infection...- Staphylococcus aureus: methicillin-susceptible S. aureus to methicillin-resistant S. aureus and vancomycin-resistant S. aureusSusan J Rehm
Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA
Clin Infect Dis 51:S176-82. 2010..Several strategies to reduce the nosocomial burden of resistance are suggested, including shortened hospital stays and outpatient parenteral antimicrobial therapy of the most serious infections... - Higher pneumococcal disease vaccination rates needed to protect more at-risk US adultsSusan J Rehm
National Foundation for Infectious Diseases, Bethesda, MD, USA
Postgrad Med 121:101-5. 2009.... 
Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial comparing daptomycin with standard therapySusan Rehm
Department of Infectious Diseases, Cleveland Clinic, OH 44195, USA
J Antimicrob Chemother 63:1034-42. 2009..Administering outpatient parenteral antimicrobial therapy in the community setting (CoPAT) is becoming more common with the increasing emphasis on controlling costs. However, few controlled trials have evaluated this treatment modality...
Staphylococcus aureus: the new adventures of a legendary pathogenSusan J Rehm
Department of Infectious Disease, Cleveland Clinic Foundation, OH 44195, USA
Cleve Clin J Med 75:177-80, 183-6, 190-2. 2008..Another worrisome trend is increasing resistance to vancomycin (Vancocin)...- Successful administration of quinupristin/dalfopristin in the outpatient settingS J Rehm
Department of Infectious Disease, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195, USA
J Antimicrob Chemother 47:639-45. 2001..In this group of patients, for those who had difficult-to-treat infections, intravenous quinupristin/dalfopristin therapy was generally effective and safe outside the hospital setting... - The far-reaching impact of antimicrobial resistanceSusan J Rehm
Cleveland Clinic, Cleveland, Ohio 44195, USA
Clin Infect Dis 45:S97-8. 2007 - Challenges in the management of serious infectionsSusan J Rehm
Department of Infectious Disease, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA
Clin Infect Dis 42:S63-4. 2006 - Two new treatment options for infections due to drug-resistant gram-positive cocciSusan J Rehm
Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
Cleve Clin J Med 69:397-401, 405-13. 2002..But their use must be tempered by their cost, toxicity, and concerns about further development of resistant strains... - Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patientsDeRen Huang
Department of Neurology, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Ann Neurol 62:34-9. 2007..MRI diagnostic criteria for PML suggest that iPML does not occur in HIV-negative individuals... - Transitioning antimicrobial stewardship beyond the hospital: the Cleveland Clinic's community-based parenteral anti-infective therapy (CoPAT) programSteven M Gordon
Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio 44195, USA
J Hosp Med 6:S24-30. 2011.... - Daptomycin versus vancomycin plus gentamicin for treatment of bacteraemia and endocarditis due to Staphylococcus aureus: subset analysis of patients infected with methicillin-resistant isolatesSusan J Rehm
Cleveland Clinic, Cleveland, OH, USA
J Antimicrob Chemother 62:1413-21. 2008..aureus bacteraemia, clinical characteristics and treatment results in the trial's pre-specified subset of patients with MRSA were analysed... - Arterial infection and staphylococcus aureus bacteremia after transfemoral cannulation for percutaneous carotid angioplasty and stentingDaniel A Culver
Internal Medicine Residency Program, The Cleveland Clinic Foundation, Ohio 44195, USA
J Vasc Surg 35:576-9. 2002.... - Deep sternal wire infection resulting in severe pulmonary valve endocarditisSekar S Bhavani
Department of Thoracic and Cardiovascular Surgery, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
Ann Thorac Surg 82:1111-3. 2006.... - Vancomycin: a 50-something-year-old antibiotic we still don't understandAmy Schilling
Department of Infectious Disease, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195, USA
Cleve Clin J Med 78:465-71. 2011..For clinicians, it is vital to remain up-to-date with evolving definitions for vancomycin susceptibility, with new interpretations of efficacy, and with information on toxicity... - Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureusVance G Fowler
Duke University Medical Center, Durham, NC 27710, USA
N Engl J Med 355:653-65. 2006..Alternative therapies for Staphylococcus aureus bacteremia and endocarditis are needed... - Practice guidelines for outpatient parenteral antimicrobial therapy. IDSA guidelinesAlan D Tice
John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96813, USA
Clin Infect Dis 38:1651-72. 2004 - Infections in hospitalized patients: what is happening and who can help?Alpesh N Amin
Hospitalist Program, University of California, Irvine, Orange, CA 92868, USA
Cleve Clin J Med 74:S2-5. 2007..Such collaboration can potentially reduce treatment failures and minimize the spread of multidrug-resistant organisms between health care settings and the community...